Showing results (1-10 of 249) with videos related to
Sort By:
Pageof 25
Oncoimmunology|April 16, 2014
Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?Luana Calabrò, Michele MaioSeminars in Oncology|May 13, 2015
Immune checkpoint blockade in malignant mesotheliomaLuana Calabrò, Michele MaioJournal of Thoracic Disease|March 7, 2018
New horizons from immunotherapy in malignant pleural mesotheliomaLuana Calabrò, Giulia Rossi, Michele MaioSeminars in Oncology|November 16, 2010
Clinical studies with anti-CTLA-4 antibodies in non-melanoma indicationsLuana Calabrò, Riccardo Danielli, Luca Sigalotti, et al.Current Oncology Reports|October 22, 2021
COVID and Lung CancerLuana Calabrò, Giulia Rossi, Alessia Covre, et al.Cancer Immunology, Immunotherapy : CII|June 27, 2018
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challengeLuana Calabrò, Aldo Morra, Robin Cornelissen, et al.Annals of the New York Academy of Sciences|October 12, 2012
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyondRiccardo Danielli, Ester Fonsatti, Luana Calabrò, et al.Cytokine & Growth Factor Reviews|July 25, 2017
Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidencesLuana Calabrò, Giovanni Luca Ceresoli, Armida D'Incecco, et al.Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
ICOS Expression as Immunologic Marker in Immune Activating Monoclonal AntibodiesRiccardo Danielli, Ornella Cutaia, Carolina Fazio, et al.Cancer Immunology, Immunotherapy : CII|September 20, 2014
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?Luana Calabrò, Giovanni Luca Ceresoli, Alessandra di Pietro, et al.Pageof 25